Ictero Medical was founded in 2018 as part of the Texas Medical Center's Biodesign Fellowship program and is developing the first cryoablation system to treat high-risk patients with gallstone disease. Ictero's catheter-based technology can be used in the interventional radiology suite to treat the gallbladder without having to remove it, ultimately allowing clinicians to offer their patients the benefits of surgery without the risk.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/29/22 | $6,000,000 | Series A |
MedTex Ventures S3 Ventures | undisclosed |
